Új korszak a 2-es típusú diabeteses betegek kezelésében A GLP-1-analóg liraglutid jelentosége egy belgyógyász szemszögébol

Translated title of the contribution: A new era in the treatment of patients with type 2 diabetes - significance of the incretin analogue liraglutide from an internist's perspective

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Therapy of patients with type-2 diabetes has two important features: in addition to the nonpharmacological approach (changes in lifestyle and diet, smoking cessation, physical exercise), pharmacological intervention is needed to reach the target level of blood sugar, and those of other cardiometabolic risk factors (blood pressure, body weight, lipids, uric acid). Unfortunately, it is a worldwide problem that only a small fraction of diabetic patients reach all these goals. This is why it is very important to have drugs which can not only decrease the blood sugar level, but have beneficial effect on several cardiometabolic factors. Antidiabetic drugs affecting incretin system, the GLP-1 analogues or -mimetics, and DPP-4 inhibitors open a new era in the treatment of diabetic patients, because in addition to the reduction of blood glucose level, they may have beneficial effects on blood pressure, blood lipids and body weight. Among these drugs the newly registered liraglutide has an important role, because it stimulates secretion of insulin in a glucose-independent manner, and it also reduces the secretion of glucagon which is a well known endogenous substance that increases blood glucose level. It is important to note that liraglutide decreases appetite, body weight and blood pressure of diabetic patients. Several clinical pharmacological studies has been completed with liraglutide. Of these the LEAD (Liraglutide Effect and Action in Diabetes) program is of outstanding value because it proved that either in monotherapy or in combination with other antidiabetics it effectively decreased blood sugar level, body weight, and had a beneficial effect on systolic blood pressure.

Translated title of the contributionA new era in the treatment of patients with type 2 diabetes - significance of the incretin analogue liraglutide from an internist's perspective
Original languageHungarian
Pages (from-to)199-202
Number of pages4
JournalLege Artis Medicinae
Volume20
Issue number3-4
Publication statusPublished - Apr 1 2010

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'A new era in the treatment of patients with type 2 diabetes - significance of the incretin analogue liraglutide from an internist's perspective'. Together they form a unique fingerprint.

  • Cite this